Part 1. Introduction 1.1 Market Definition 1.2 Key Benefit 1.3 Market Segment Part 2. Methodology 2.1 Primary 2.2 Secondary Part 3. Executive Summary Part 4. Market Overview 4.1 Introduction 4.2 Market Size and Forecast 4.3 Market Dynamics 4.3.1 Drivers 4.3.2 Restraints 4.4 Impact of COVID-19 Pandemic Part 5. Global Market for Oral Antibiotics by Class 5.1 Beta Lactam And Beta Lactamase Inhibitors 5.1.1 Market Size and Forecast 5.2 Macrolides 5.2.1 Market Size and Forecast 5.3 Quinolones 5.3.1 Market Size and Forecast 5.4 Others 5.4.1 Market Size and Forecast Part 6. Global Market for Oral Antibiotics by Application 6.1 Community-Acquired Respiratory Tract Infections (Cartis) 6.1.1 Market Size and Forecast 6.2 Dental 6.2.1 Market Size and Forecast 6.3 Urinary Tract Infections (Utis) 6.3.1 Market Size and Forecast 6.4 Others 6.4.1 Market Size and Forecast Part 7. Global Market for Oral Antibiotics by Drug Origin 7.1 Natural 7.1.1 Market Size and Forecast 7.2 Semisynthetic 7.2.1 Market Size and Forecast 7.3 Synthetic 7.3.1 Market Size and Forecast Part 8. Global Market for Oral Antibiotics by Drug Type 8.1 Branded 8.1.1 Market Size and Forecast 8.2 Generics 8.2.1 Market Size and Forecast Part 9. Key Competitor Profiles 9.1 Abbott Laboratories 9.2 Allergan PLC 9.3 GlaxoSmithKline plc (GSK) 9.4 Merck & Co. 9.5 Mylan N.V. 9.6 Novartis International AG 9.7 Pfizer Inc. 9.8 Roche Holding AG 9.9 Sanofi S.A. *LIST IS NOT EXHAUSTIVE Part 10. Patent Analysis 10.1 Patent Statistics 10.2 Regional Analysis 10.3 Trends Analysis DISCLAIMER ABOUT GEN CONSULTING COMPANY